Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo de Witte

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
Blood|August 5, 2006
Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytesJurgen A F Marteijn, Laurens T van der Meer, Liesbeth Van Emst, et al.
Blood|May 19, 2010
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Josy Reiffers, et al.
Haematologica|October 13, 2018
Association of anemia with health-related quality of life and survival: a large population-based cohort studyHanneke J C M Wouters, Melanie M van der Klauw, Theo de Witte, et al.
Plos One|December 1, 2016
Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS PatientsSaskia Mc Langemeijer, Niccolo Mariani, Ruth Knops, et al.
Cancer|July 31, 2009
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysisAlois Gratwohl, Martin Stern, Ronald Brand, et al.
Haematologica|November 22, 2011
Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia GroupFrédéric Baron, Stefan Suciu, Sergio Amadori, et al.
Haematologica|March 7, 2007
Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 studyXavier Thomas, Stefan Suciu, Bernard Rio, et al.
Biochimica Et Biophysica Acta|May 30, 2002
Bcl-2 protects against apoptosis induced by antimycin A and bongkrekic acid without restoring cellular ATP levelsAniek O de Graaf, Jules P P Meijerink, Lambert P van den Heuvel, et al.
Haematologica|June 14, 2006
The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromesTheo de Witte, Ronald Brand, Anja van Biezen, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 27, 2025
Estimating the Causal Effect of Realistic Treatment Strategies Using Longitudinal Observational DataYingying Zhang, Alastair Bennett, Andrea Manca, et al.
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
Blood|August 5, 2006
Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytesJurgen A F Marteijn, Laurens T van der Meer, Liesbeth Van Emst, et al.
Blood|May 19, 2010
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remissionNorbert-Claude Gorin, Myriam Labopin, Josy Reiffers, et al.
Haematologica|October 13, 2018
Association of anemia with health-related quality of life and survival: a large population-based cohort studyHanneke J C M Wouters, Melanie M van der Klauw, Theo de Witte, et al.
Plos One|December 1, 2016
Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS PatientsSaskia Mc Langemeijer, Niccolo Mariani, Ruth Knops, et al.
Cancer|July 31, 2009
Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysisAlois Gratwohl, Martin Stern, Ronald Brand, et al.
Haematologica|November 22, 2011
Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia GroupFrédéric Baron, Stefan Suciu, Sergio Amadori, et al.
Haematologica|March 7, 2007
Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 studyXavier Thomas, Stefan Suciu, Bernard Rio, et al.
Biochimica Et Biophysica Acta|May 30, 2002
Bcl-2 protects against apoptosis induced by antimycin A and bongkrekic acid without restoring cellular ATP levelsAniek O de Graaf, Jules P P Meijerink, Lambert P van den Heuvel, et al.
Haematologica|June 14, 2006
The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromesTheo de Witte, Ronald Brand, Anja van Biezen, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 27, 2025
Estimating the Causal Effect of Realistic Treatment Strategies Using Longitudinal Observational DataYingying Zhang, Alastair Bennett, Andrea Manca, et al.
Pageof 16